NovAliX's Graffinity Pharmaceuticals GmbH subsidiary will use its SPR imaging screening technology to discover small molecule compounds against an undisclosed target from Shionogi

NovAliX S.A.S.

France / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Shionogi & Co. Ltd.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced